Assyro AI

FDA Orange Book · active-ingredient family

Isosorbide mononitrate

Isosorbide mononitrate is approved as 3 brand and 20 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:IMDUR · NDA 020225

3

Brand (NDA)

20

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet, tablet, extended release

ProductApplicantApplicationTEApproved
IMDURRLD×3SCHERING PLOUGHNDA 020225Aug 12, 1993
MONOKETRLD×2OMNIVIUM PHARMSNDA 020215ABJun 30, 1993
ISMOPROMIUS PHARMANDA 019091Dec 30, 1991

Generic (ANDA) products (20)

ProductApplicantApplicationTEApproved
ISOSORBIDE MONONITRATE×2ANI PHARMSANDA 075147ABMar 27, 2026
ISOSORBIDE MONONITRATE×3ZYDUS PHARMSANDA 218255Feb 15, 2024
ISOSORBIDE MONONITRATE×3SHANDONGANDA 214115ABFeb 08, 2024
ISOSORBIDE MONONITRATE×3AUROBINDO PHARMAANDA 216557ABNov 07, 2022
ISOSORBIDE MONONITRATE×3RICONPHARMA LLCANDA 210918ABNov 05, 2018
ISOSORBIDE MONONITRATEDEXCEL LTDANDA 210822ABAug 29, 2018
ISOSORBIDE MONONITRATE×3ACCORD HLTHCAREANDA 209684Oct 24, 2017
ISOSORBIDE MONONITRATE×2DEXCEL LTDANDA 075522ABSep 20, 2016
ISOSORBIDE MONONITRATETORRENT PHARMSANDA 200270ABJun 03, 2011
ISOSORBIDE MONONITRATE×2TORRENT PHARMSANDA 200495ABJun 03, 2011
ISOSORBIDE MONONITRATE×3STRIDES PHARMA INTLANDA 090598Aug 11, 2010
ISOSORBIDE MONONITRATE×2HIKMA INTL PHARMSANDA 076813Mar 30, 2006
ISOSORBIDE MONONITRATE×3IVAX SUB TEVA PHARMSANDA 075448Aug 07, 2001
ISOSORBIDE MONONITRATEHIKMA PHARMSANDA 075361Oct 05, 2000
ISOSORBIDE MONONITRATE×3ZYDUS HLTHCAREANDA 075395ABMar 16, 2000
ISOSORBIDE MONONITRATE×3CHARTWELL MOLECULARANDA 075155ABJan 13, 2000
ISOSORBIDE MONONITRATESKYEPHARMA AGANDA 075166Oct 07, 1999
ISOSORBIDE MONONITRATE×2ACTAVIS ELIZABETHANDA 075306Dec 31, 1998
ISOSORBIDE MONONITRATE×2GENUSANDA 075037ABOct 30, 1998
ISOSORBIDE MONONITRATEALKERMES GAINESVILLEANDA 075041Sep 22, 1998

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Isosorbide mononitrate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.